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Background: Rabies is the most severe and neglected public health problem in India. Management of animal bite
with post exposure prophylaxis is the only existent strategy to prevent rabies related deaths. Cost-effective and
sustainable programme for provision of post exposure prophylaxis (PEP) is needed in India.
Methods: In this study, we have documented the experience of implementation of intra-dermal anti rabies vaccination
in Animal Bite Management (ABM) clinic at Primary Health Centre (PHC). This study facility belonged to Comprehensive
Rural Health Services Project, Ballabgarh in Faridabad district of Haryana. Hospital service record of ABM clinic was
analyzed and various feasibility issues such as costing of services, vaccine wastage and other operational issues in
providing PEP services at PHC level were documented.
Results: A total of 619 patients were treated in the ABM clinic. Service utilization of ABM clinic was increased by 38% in
the second year of implementation. Mean age of the patients was 23.9 years (SD: 18.8) and majority (70.4%) were
males. Majority (86%) of the patients received the first dose of anti-rabies vaccine within the recommended 48 hours. A
total 446 vaccine vials (1 ml) were consumed of which 20.8% was contributed in vaccine wastage. User-fee (350 Indian
Rupees) collected from the patients. User-fee was re-used to purchase vaccines, intradermal (ID) syringes and other
consumables required to ensure regular availability of ARV services at the PHC.
Conclusions: This study demonstrated the cost-effective and sustainable model of provision of PEP against rabies at
primary care level. ID PEP provision at primary care level not only address the unmet need of animal bite management
in the community also reduces the out of pocket expenditure of the patients.
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Globally, annual incidence of human rabies is estimated to
be between 30,000- 70,000 with more than 90% of cases
reported from developing countries. This contributes to
20,000 deaths attributed to Rabies and 17.4 million cases
of animal bite per annum. The highest numbers of human
deaths due to rabies are observed in India and Philippines
[1]. India accounts for 36% of the Global and 65% of the
Asian rabies related deaths [2]. In India, a nationwide sur-
vey reported that annual incidence of animal bites was
1.7% (2003), more common in rural areas, among children* Correspondence: harshalsalve@ymail.com
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unless otherwise stated.and low income groups [2]. In spite of this disease burden,
rabies is a neglected infectious disease in India. The main
biting animals are stray dog followed by cat [2]. Rabies can
be averted only by effective pre- exposure prophylaxis
(PrEP) or post-exposure prophylaxis (PEP) [3]. PEP in-
cludes anti-rabies vaccine administration, and for severe
categories of exposure, infiltration of purified rabies im-
munoglobulin (RIG) in and around the wound [4]. In low
and middle income countries, RIG is rarely used as it is
expensive [5,6] and not regularly available [7,8]. Hence,
only post exposure vaccination is provided to patients with
animal bites [9]. In the year 2007, out of all animal bite
cases, 50% received PEP in India. Out of this almost 40%
got nerve tissue vaccine (NTV) due to its low cost and
free availability [8]. Government of India (GOI) bannedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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mal bite are forced to purchase Tissue Culture Vaccine
(TCV). Non-availability or irregular supply in public
health system and high cost of TCV contributes to signifi-
cant out-of-pocket expenditure (OOP) in the range of
1500-1800 Indian Rupees (Rs) for five doses under PEP.
High OOP limits health care seeking by most of the ani-
mal bite-patients. In 1997, World Health Organization
(WHO) recommended intra-dermal (ID) TCV administra-
tion in resource-poor setting [10]. Immunological re-
sponse and effectiveness of PEP via intra-dermal route has
been found to be similar to other intra-muscular regimens
[11]. In the year 2006, GOI recommended use of ID TCV
administration under PEP [12]. Although some Indian
states provide TCV at free of cost through few public
health facilities, erratic supply reduces its utilization. Loss
of wages due to required multiple visits to the health facil-
ity has been incriminated in poor compliance to PEP. This
has been also identified as a reason for increased rabies
deaths especially in rural areas [12]. Therefore, the possi-
bility of PEP provision for rabies via self-sustaining mech-
anism at primary care level becomes worth exploring.
As an initiative under National Rural Health Mission
(NRHM), a patient welfare society or Rogi/Swasthya Kalyan
Samiti (RKS/SKS) has been formed at all Primary Health
Centres (PHCs) in India. The SKS is a registered society
with the Medical Officer (MO) as the Chairman and se-
lected healthcare provider and civil society representatives
as members. Some funds are given to these SKSs by GOI
through NRHM [13]. SKS members are authorized to
utilize the funds. These societies can also levy user-fees
which can be used for welfare of patients seeking health-
care. Encouraged by this financial flexibility, we planned to
offer a comprehensive care package for patients with ani-
mal bite. The objective of this study is to document various
feasibility issues related with provision of rabies ID-PEP ser-
vices at a rural Primary Health Centre (PHC) in Haryana
state in north India.
Methods
Present study was carried out in one of the PHCs under
Comprehensive Rural Health Services Project (CRHSP)
Ballabgarh of All India Institute of Medical Sciences,
New Delhi [14]. Since more than three decades, prevent-
ive, promotive and curative services had been provided
through this PHC (Chhainsa) to the population of 47,
000 (year 2012). Curative services were provided
through daily general outpatient clinic at the PHC. In
the latter half of the year 2010, we realized that many
patients were approaching the PHC seeking treatment
for animal bites. At that time, they were provided first
aid and referred to district hospital for PEP. The district
hospital was 30 kilometers from the PHC. The distance
and OOP expenditure led to many of the patients notseeking further care as reported by health workers,
Accredited Social Health Activists (ASHA), and the
family members themselves. At that time both govern-
ment hospitals and private practitioners were following
intramuscular regimen (days 0-3-7-14-28 – 90) for PEP
without RIG for animal bite management.
An Animal Bite Management (ABM) clinic was started
at the PHC in December 2010. Purified Chick Embryo
Cell (PCEC) Vaccine and ID syringes were purchased
using the funds provided by NRHM to SKS. We followed
a two site (both deltoid regions), four doses (0, 3, 7, 28
days), intra-dermal regimen known as the ‘Up-dated Thai
Regimen’ [11]. In this regimen, 0.1 ml ARV was given at
both arm at deltoid region. Each patient received 0.2 ml
ARV on vaccination day. We considered Day 0 as the day
of administration of first dose of ID rabies vaccine, and
this may or may not be the day of animal bite. Day 14 was
skipped as compared to the IM regimen. In case of a bite-
site on the arm, the vaccine was given by the ID route on
supra-scapular areas [5]. Since the patient load was ex-
pected to be small at the beginning of this service, we
decided to offer vaccination on fixed days (Mondays,
Wednesdays and Saturdays). The schedule was made so. If
a patient reported on other days, and if the next vaccin-
ation day was within 2 days (48 hours) of the date of ex-
posure, patient was called on the that day for PEP.
In the ABM clinic, we followed WHO protocol for ani-
mal bite management. After confirmation of diagnosis, we
provided thorough wound washing with soap and running
water, wound care and tetanus prophylaxis (if not given
before). We collected information on socio-demographic
characteristics; earlier history of animal bite and PEP, se-
lected characteristics of the biting animal. The provider
then assessed the wound and decided on PEP schedule in-
cluding other symptomatic treatment and antibiotics. Ad-
vices were given emphasizing the severity of rabies and
the need to adhere to the schedule, do’s and don’ts in case
of animal bite. For cases requiring RIG, referral was made
to the district hospital. The SKS committee decided to
levy Rs. 350 from users of ABM Clinic services. Very poor
patients, widows and patients belonging to Below Poverty
Line (BPL) were exempted from the payment of user-fee.
Record keeping
Record of the patients in the form of brief exposure his-
tory, previous PEP history and socio-demographic infor-
mation was maintained. This record was obtained and
maintained by the staff nurses and ANM posted at the
PHC. Contact numbers of the individual patients were
collected to do follow up and to remind patients of PEP
scheduled date in case of default. In the follow up, infor-
mation about any vaccine related side effects and rabies
related deaths were obtained on telephone. Record of
user-fee collected was maintained by the medical officer
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was maintained by the medical officer in-charge on be-
half of SKS to deposit the amount so collected from
PEP. The SKS commissioned yearly audit of account by
the authority from district headquarter according to
NRHM guidelines.Training of PHC staff
ID PEP was administered by staff nurses/ANM posted at
the PHC. These staff nurses/ANM were involved in rou-
tine vaccination programme and had adequate technical
skills in ID administration of ARV which was reinforced
from time to time. Sensitization of PHC staff regarding
cause of rabies, transmission of rabies, preventive mea-
sures and ID PEP was carried out by the medical officers
posted at the PHC [5].
Information Education and Communication (IEC)
Health workers, ASHA, Anganwadi worker (AWW) and
opinion leaders of the community such as village headman
(Sarpanch), school teacher etc. were involved in IEC. This
helped in improved use of ABM services at the PHC
(Figure 1).
In this paper, we have described our experience of
ABM clinic from January 2011 to December 2012. We
explored various feasibility issues such as cost effective-
ness, vaccine wastage and other operational issues in
providing PEP services at PHC level.
Ethical issues
Ethical clearance for the study was obtained from Ethical
Committee of All India Institute of Medical Sciences,
New Delhi.Figure 1 Distribution of ABM clinic attendee by period (Jan 2011 to DResults
Socio-demographic profile of patients attending
ABM clinic
A total of 619 patients were treated in the ABM clinic of
PHC. Service use of ABM clinic was increased by 38% in
the year 2012 as compared to year 2011. Patient burden
at ABM clinic showed increasing trend during study
period (Figure 1). Mean age of the patients was 23.9 years
(SD: 18.8) and majority (70.4%) were males (Table 1).
Characteristics of the treatment availed at ABM clinic
Nearly 495 (80%) of the wounds were bleeding wounds
(Class III). In about 99 (16%), the skin was just broken
(Class II), and in 25 (4%) the skin was intact (Class I). Ma-
jority 533 (86%) of the patients received the first dose of
ARV within the recommended 48 hours. Mean (SD) time
interval between exposure and first dose of ARV was
2.2 days (SD: 4.2). Of total, 452 (73.0%) patients completed
full course of PEP. Among the patients who completed
treatment, 375 (82.8%) adhered to the schedule. None of
the patients received PEP reported with any severe com-
plication due to vaccine or rabies related death during one
year post vaccination.
Consumption of vaccines and other consumables
During study period, 619 animal bite-patients reported to
the ABM clinic, and a total 446 vaccine vials (1 ml) were
consumed for PEP. One vial was used to vaccinate five pa-
tients (0.2 ml each) on the scheduled vaccination day. As
per the recommendations of the manufacturer opened vial
was used within 8 hours of reconstitution. The remaining
vaccine, if any, was thereafter discarded. This resulted in
892 ID doses (~90 vials) being wasted. In total, 1890 ID
syringes were used during study period for PEP.ec 2012).
Table 1 Socio-demographic profile of the patients
attended ABM clinic (N = 619)
Age group (years) Number Percentage
<=18 years 303 48.9
19 to 35 years 179 29.0
36 to 59 years 94 15.2




Distance of residence from
study facility (PHC)
Number Percentage
< 5 kms 245 39.6
> 5 kms 374 60.4
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Vaccine was stored in Ice-lined refrigerator (ILR) at 4 to
8 Degree Celsius along with other vaccines under routine
immunization programme. ILR with capacity of 70 litters
was found to be enough for storage of 100 vaccine vials at
any given point of time. The ANM posted at PHC main-
tained the temperature record for ILR twice daily. Record
showed that temperature was maintained at 2 – 8 degree
Celsius throughout the study period.
Costing of the services
ARV was not available through government supply. In the
initial period, vaccine was bought through the funds avail-
able at PHC under SKS funds following prescribed norms.
The cost of one vial that contained 1 ml or 5 ID doses was
Rs. 300. User-fee (Rs. 350) collected from the patients was
re-used to purchase vaccines, ID syringes and other con-
sumables required to make sure regular availability of PEP
services at the PHC. One vial and four ID syringes were
used to complete PEP schedule for one patient. Hence,
total average cost incurred for provision of PEP to one pa-
tient was Rs. 315. Thus we gained Rs. 35 from each user
charge paying patient. This mechanism helped us to offer
this service to poor patients free of cost and to compen-
sate for vaccine wastage. During study period, 76 (12.3%)
patients were exempted from the user-fee. Vaccine wast-
age cost around Rs. 2700 during period of two years.
Other services such as tetanus toxoid, first-aid and antibi-
otics were provided free of cost to all the patients.Burden on existing health staff providing the services
Daily patient (old + new) load at ABM clinic was 20-25.
Nursing staff had to spend 6-8 minutes per patient for
ARV administration and record filling. This resulted in
120-200 minutes per ARV vaccination day. Medical Officer
In-charge had to spend approximately 24 hours per monthfor supervision and procurement of vaccines and other
consumables for ABM clinic.
Discussion
In this study, we have documented our experience of pro-
viding of Rabies PEP and related care at primary care level
in rural community of north India. The PCEC vaccine
used in the ABM clinic has been considered to generate
equal immunological response as that of HDC vaccine but
at a cheaper rate [15]. Intradermal Up-dated Thai Regi-
men (2 -2 -2-0-2) was used for PEP whose safety and im-
munogenicity is well documented in Indian population
[16]. Usefulness and cost-effectiveness of ID ARV among
population who cannot afford it is also well documented
[17]. High attendance in ABM clinic reflected acceptance
and utility of ARV services at primary care level. This
programme can serve as a model for delivery of this ser-
vice in resource-poor setting using the nationally approved
funding and treatment guidelines. Drug Controller Gen-
eral of India (DCGI) has already approved PCECV for use
of reduced dosage intra-dermal vaccination regimen in ra-
bies PEP [14].
The NRHM has endorsed user-fee strategy to create local
resources which would then be utilized locally to improve
service availability and quality [13]. In developing country
like India, user-fee mechanism affects the utilization of
health service by increasing OOP expenditure and
limitation to access to health service by ability to pay
[18]. Patients had to pay 75% - 80% less amount to
avail PEP from the PHC as compared to that of private
practitioners who usually charged Rs. 1800 to Rs. 1900. If
ARV services were available at district hospital free of cost,
then patient from study area had to travel approximately
20-30 kilometers to avail the service. For travel by usually
available mode of transport the patient would have spent
approximately Rs. 40 - Rs. 60 for each of the five visits.
Hence, an amount of Rs. 200 - Rs.300 travel would have
been incurred by the patient on account of travel cost.
Most of the patients of ABM clinic were daily wage la-
borer; hence availing services at district hospital would
have cost loss of daily wage Rs. 200 - Rs. 300 per visit. Pa-
tient had to make five visits to complete the ARV IM
schedule. Hence, total OOP for the patient due to animal
bite could have been Rs. 1200 to Rs. 1800. However, this
study demonstrated 70% - 80% reduction in OOP expend-
iture of patients on ARV. Also, indirect cost involved in
terms of man-hour cost, travel time and expenses per visit
was reduced. This was also evident from yearly increase in
ABM clinic service use at PHC in this study.
Majority of patients that attended ABM clinic were of
younger age group and males. The incidence of animal
bites has been reported to be higher in these groups [3].
Majority of the attendees reported residing far from the
PHC (>5 kms away). This could be attributed to widespread
Salve et al. BMC Health Services Research 2014, 14:278 Page 5 of 6
http://www.biomedcentral.com/1472-6963/14/278unmet need and acceptability of ARV services in the com-
munity. One fourth of the patients did not complete entire
PEP regimen. Similar findings were reported by Rasania
et al. in their study at Primary Health Center in New Delhi
[19]. This could be due to the need of multiple visits to
health facility and hence having economic consequences to
the patients.
In this study, ID ARV was provided by nursing staff
posted at PHC who were already trained in ID BCG vac-
cination in routine immunization programme. Hence,
availability of healthcare provider for ID route of adminis-
tration would not be an issue if the model is emulated
elsewhere in the country in similar setting. The ABM ser-
vices can be provided as part of the existing primary
health setting and no extra human resources and funds
need to be mobilized.
In the initial phases of clinic, patient load was low. ABM
clinic was operational for three days week (Monday,
Wednesday and Saturday) (Figure 1). One of the limita-
tions encountered with this method was that the day 3
dose fell on the 2nd day for patients receiving the first dose
on Mondays and Saturdays. However this was essential to
minimize vaccine wastage. Also, significant amount of
duty time (8 – 10 minute per person) of staff nurse/ANM
was expended for PEP on vaccination day. Anti-rabies pas-
sive prophylaxis was not provided due to high cost. But
needy patients were referred to higher centers for the
same. None of the previous study in India has reported
use of anti-rabies antibody in public health system perhaps
due to non-availability in government supply and high
cost [2,20].
PEP service was not provided on all days in week to
minimize the vaccine wastage. This limitation could be
overcome by providing this service on all days a week pro-
vided patient load increased to an optimum level. Exemp-
tion from user-fees was provided on the basis of availability
of BPL cards irrespective of actual socio-economic status of
the family. This limitation was also documented in studies
evaluating user-fees dependent services [20]. This financial
mechanism will not be relevant where regular ARV is pro-
vided through government supply at primary care level as
prevalent in many states of India.
Conclusions
This study provides initial evidence of sustainable and
cost effective model of PEP against rabies services
provision at primary care level where its availability
through government supply is a problem. It can also be
argued that provision of such services may increase the
trust of public in government healthcare system and in-
crease the utilization of other services available but not
popular at primary care level. Provision of services at
primary care level will be one the way to attract popula-
tion towards public health sectors.Competing interests
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